T2 Biosystems, Inc. (TTOO)
NASDAQ: TTOO · IEX Real-Time Price · USD
2.957
-0.033 (-1.10%)
Apr 19, 2024, 10:22 AM EDT - Market open
T2 Biosystems Stock Forecast
Stock Price Forecast
The 1 analyst with a 12-month price forecast for T2 Biosystems stock has a target of 7.00, which predicts an increase of 136.73% from the current stock price of 2.96.
Analyst Consensus: Hold
* Price targets were last updated on Jul 13, 2023.
Analyst Ratings
According to 1 stock analyst, the rating for T2 Biosystems is "Hold". This means that the analyst believes this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Nov '23 | Dec '23 | Jan '24 | Feb '24 | Mar '24 | Apr '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 2 | 2 | 2 | 2 | 2 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 2 | 2 | 2 | 2 | 2 | 1 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Alliance Global Partners | Alliance Global Partners | Hold Maintains $12 → $7 | Hold | Maintains | $12 → $7 | +136.73% | Jul 13, 2023 |
| Alliance Global Partners | Alliance Global Partners | Hold Maintains $220 → $150 | Hold | Maintains | $220 → $150 | +4,972.71% | Jan 24, 2023 |
| Canaccord Genuity | Canaccord Genuity | Strong Buy → Hold Downgrades $1,250 → $250 | Strong Buy → Hold | Downgrades | $1,250 → $250 | +8,354.51% | Oct 14, 2022 |
| Alliance Global Partners | Alliance Global Partners | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Jul 7, 2022 |
| BTIG | BTIG | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Jul 7, 2022 |
Financial Forecast
Revenue This Year
10.20M
from 7.19M
Increased by 41.80%
Revenue Next Year
37.43M
from 10.20M
Increased by 267.00%
EPS This Year
-6.49
from -19.19
EPS Next Year
-0.05
from -6.49
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 10.5M | 38.5M | 54.1M | 71.3M | 86.7M |
| Avg | 10.2M | 37.4M | 52.5M | 69.3M | 84.3M |
| Low | 9.8M | 36.0M | 50.5M | 66.5M | 80.9M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 46.0% | 277.8% | 44.5% | 35.7% | 25.2% |
| Avg | 41.8% | 267.0% | 40.3% | 31.8% | 21.6% |
| Low | 36.2% | 252.6% | 34.8% | 26.7% | 16.9% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | -6.68 | -0.05 | -4.20 | -3.15 | -3.15 |
| Avg | -6.49 | -0.05 | -4.08 | -3.06 | -3.06 |
| Low | -6.23 | -0.05 | -3.92 | -2.94 | -2.94 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | - | - | - | - |
| Avg | - | - | - | - | - |
| Low | - | - | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.